Huge amount of food are thrown out every day. A lot is bread that has gone stale. With enzymes we can change that.

Novozymes is redefining hyaluronic acid (HA) with Hyasis, the next generation of high-quality HA based on the safe bacteria Bacillus subtilis, expanding the number of possible applications of HA in medical device and pharma products.

Novozymes’ state of the art facility in China is dedicated to produce the first fully Q7 cGMP compliant hyaluronic acid for use in biomedical and pharmaceutical applications.

Novozymes' Kalundborg facility has a new reactor that turns waste water into biogas, delivering as much electricity as seven, offshore wind turbines.

Novozymes’ CEO, CSO and Executive Vice President of Business Development explain the growing role of partnerships, and the benefits and opportunities these offer the company.

As the world becomes more focused on sustainability, ensuring that the cleaning products we use are safe for people and the environment is becoming increasingly important. Novozymes is the leading supplier of enzymes and beneficial microorganisms that naturally improve the efficiency of cleaning solutions in an increasing number of applications. Our technologies enable cleaning of stains from carpet and hard surfaces and elimination of organics that produce bad odor.

At Novozymes, we combine the specific application knowledge of our customers with our unique knowledge around our biological based solutions such as recombinant albumin, half-life extension and hyaluronic acid with. We work closely with companies to deliver improved performance and safety for next generation of medical device and pharmaceutical products.

Novozymes is the world leader in bioinnovation with more than 60 years history of innovation. Novozymes develops and produces industrial enzymes, microorganisms and biopharmaceutical ingredients that re-engineer thousands of everyday products in order to deliver enhanced performance, energy cost savings and lower raw material costs for our customers. Novozymes’ microorganisms and biopharmaceutical ingredients provide safe, effective and sustainable products for agriculture, the healthcare industry, cleaning and wastewater treatment.

A typical household is packed with products made from oil. Novozymes emptied a household of all oil based products to draw attention to the fact that there is an alternative: a biobased economy based on plants and waste.

The albumin based technology can be used for the reduction of drug dosing frequency and the increase of patient compliance. Genetic fusion – Albufuse® Flex is suitable for non-synthetic peptides whereas chemical conjugation – Recombumin® Flex is most appropriate for non-natural or synthesized peptides.